A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy

Bibliographic Details
Main Author: Masatoshi Kudo
Format: Article
Language:English
Published: Karger Publishers 2020-03-01
Series:Liver Cancer
Online Access:https://www.karger.com/Article/FullText/505189
id doaj-00eb22fe02c346e983f651a0ebf3ec8d
record_format Article
spelling doaj-00eb22fe02c346e983f651a0ebf3ec8d2020-11-25T03:18:56ZengKarger PublishersLiver Cancer2235-17951664-55532020-03-019211913710.1159/000505189505189A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination TherapyMasatoshi Kudohttps://www.karger.com/Article/FullText/505189
collection DOAJ
language English
format Article
sources DOAJ
author Masatoshi Kudo
spellingShingle Masatoshi Kudo
A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy
Liver Cancer
author_facet Masatoshi Kudo
author_sort Masatoshi Kudo
title A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy
title_short A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy
title_full A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy
title_fullStr A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy
title_full_unstemmed A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy
title_sort new era in systemic therapy for hepatocellular carcinoma: atezolizumab plus bevacizumab combination therapy
publisher Karger Publishers
series Liver Cancer
issn 2235-1795
1664-5553
publishDate 2020-03-01
url https://www.karger.com/Article/FullText/505189
work_keys_str_mv AT masatoshikudo anewerainsystemictherapyforhepatocellularcarcinomaatezolizumabplusbevacizumabcombinationtherapy
AT masatoshikudo newerainsystemictherapyforhepatocellularcarcinomaatezolizumabplusbevacizumabcombinationtherapy
_version_ 1724624874526212096